Clinical Challenges

ASH: DLBCL and CLL

American Society of Hematology

More in ASH: DLBCL and CLL

Clinical Challenges: Treating CLL When BTK Inhibition Fails

Strategies for patients who progress and those intolerant of ibrutinib

Dec 11, 2018
image